Clinical value of FDG PET or PET/CT in urinary bladder cancer: A systemic review and meta-analysis

Yu Yu Lu, Jin Hua Chen, Ji An Liang, Hsin Yi Wang, Cheng Chieh Lin, Wan Yu Lin, Chia Hung Kao

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Aim: The purpose of the current study was to conduct a systemic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of FDG PET or PET/CT in urinary bladder cancer. Materials and methods: The authors conducted a systematic MEDLINE search of articles published between January 2000 and December 2010. Two reviewers independently assessed the methodological quality of each study. We conducted a meta-analysis of pooled sensitivity and specificity in detecting primary and metastatic lesions of bladder cancer. Results: Six studies met the inclusion criteria. The pooled sensitivity and specificity of PET/CT for primary lesion detection of bladder cancer were 0.90 (95% CI: 0.70-0.99) and 1.00 (95% CI: 0.74-1.00), respectively. The pooled sensitivity and specificity of FDG PET or PET/CT for staging or restaging (metastatic lesions) of bladder cancer were 0.82 (95% CI: 0.72-0.89) and 0.89 (95% CI: 0.81-0.95), respectively. Conclusion: The diagnostic accuracy of FDG PET or PET/CT is good in metastatic lesions of urinary bladder cancer. Due to the small number of patients and limited number of studies analyzed, the diagnostic capability of FDG PET or PET/CT in detection of primary bladder wall lesions could not be assessed.

Original languageEnglish
Pages (from-to)2411-2416
Number of pages6
JournalEuropean Journal of Radiology
Volume81
Issue number9
DOIs
Publication statusPublished - Sep 2012
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Meta-Analysis
Sensitivity and Specificity
MEDLINE
Urinary Bladder

Keywords

  • FDG PET
  • Meta-analysis
  • PET/CT
  • Systemic review
  • Urinary bladder cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Clinical value of FDG PET or PET/CT in urinary bladder cancer : A systemic review and meta-analysis. / Lu, Yu Yu; Chen, Jin Hua; Liang, Ji An; Wang, Hsin Yi; Lin, Cheng Chieh; Lin, Wan Yu; Kao, Chia Hung.

In: European Journal of Radiology, Vol. 81, No. 9, 09.2012, p. 2411-2416.

Research output: Contribution to journalArticle

Lu, Yu Yu ; Chen, Jin Hua ; Liang, Ji An ; Wang, Hsin Yi ; Lin, Cheng Chieh ; Lin, Wan Yu ; Kao, Chia Hung. / Clinical value of FDG PET or PET/CT in urinary bladder cancer : A systemic review and meta-analysis. In: European Journal of Radiology. 2012 ; Vol. 81, No. 9. pp. 2411-2416.
@article{0708c3e86acd4df39ada55e32990b666,
title = "Clinical value of FDG PET or PET/CT in urinary bladder cancer: A systemic review and meta-analysis",
abstract = "Aim: The purpose of the current study was to conduct a systemic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of FDG PET or PET/CT in urinary bladder cancer. Materials and methods: The authors conducted a systematic MEDLINE search of articles published between January 2000 and December 2010. Two reviewers independently assessed the methodological quality of each study. We conducted a meta-analysis of pooled sensitivity and specificity in detecting primary and metastatic lesions of bladder cancer. Results: Six studies met the inclusion criteria. The pooled sensitivity and specificity of PET/CT for primary lesion detection of bladder cancer were 0.90 (95{\%} CI: 0.70-0.99) and 1.00 (95{\%} CI: 0.74-1.00), respectively. The pooled sensitivity and specificity of FDG PET or PET/CT for staging or restaging (metastatic lesions) of bladder cancer were 0.82 (95{\%} CI: 0.72-0.89) and 0.89 (95{\%} CI: 0.81-0.95), respectively. Conclusion: The diagnostic accuracy of FDG PET or PET/CT is good in metastatic lesions of urinary bladder cancer. Due to the small number of patients and limited number of studies analyzed, the diagnostic capability of FDG PET or PET/CT in detection of primary bladder wall lesions could not be assessed.",
keywords = "FDG PET, Meta-analysis, PET/CT, Systemic review, Urinary bladder cancer",
author = "Lu, {Yu Yu} and Chen, {Jin Hua} and Liang, {Ji An} and Wang, {Hsin Yi} and Lin, {Cheng Chieh} and Lin, {Wan Yu} and Kao, {Chia Hung}",
year = "2012",
month = "9",
doi = "10.1016/j.ejrad.2011.07.018",
language = "English",
volume = "81",
pages = "2411--2416",
journal = "European Journal of Radiology",
issn = "0720-048X",
publisher = "Elsevier Ireland Ltd",
number = "9",

}

TY - JOUR

T1 - Clinical value of FDG PET or PET/CT in urinary bladder cancer

T2 - A systemic review and meta-analysis

AU - Lu, Yu Yu

AU - Chen, Jin Hua

AU - Liang, Ji An

AU - Wang, Hsin Yi

AU - Lin, Cheng Chieh

AU - Lin, Wan Yu

AU - Kao, Chia Hung

PY - 2012/9

Y1 - 2012/9

N2 - Aim: The purpose of the current study was to conduct a systemic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of FDG PET or PET/CT in urinary bladder cancer. Materials and methods: The authors conducted a systematic MEDLINE search of articles published between January 2000 and December 2010. Two reviewers independently assessed the methodological quality of each study. We conducted a meta-analysis of pooled sensitivity and specificity in detecting primary and metastatic lesions of bladder cancer. Results: Six studies met the inclusion criteria. The pooled sensitivity and specificity of PET/CT for primary lesion detection of bladder cancer were 0.90 (95% CI: 0.70-0.99) and 1.00 (95% CI: 0.74-1.00), respectively. The pooled sensitivity and specificity of FDG PET or PET/CT for staging or restaging (metastatic lesions) of bladder cancer were 0.82 (95% CI: 0.72-0.89) and 0.89 (95% CI: 0.81-0.95), respectively. Conclusion: The diagnostic accuracy of FDG PET or PET/CT is good in metastatic lesions of urinary bladder cancer. Due to the small number of patients and limited number of studies analyzed, the diagnostic capability of FDG PET or PET/CT in detection of primary bladder wall lesions could not be assessed.

AB - Aim: The purpose of the current study was to conduct a systemic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of FDG PET or PET/CT in urinary bladder cancer. Materials and methods: The authors conducted a systematic MEDLINE search of articles published between January 2000 and December 2010. Two reviewers independently assessed the methodological quality of each study. We conducted a meta-analysis of pooled sensitivity and specificity in detecting primary and metastatic lesions of bladder cancer. Results: Six studies met the inclusion criteria. The pooled sensitivity and specificity of PET/CT for primary lesion detection of bladder cancer were 0.90 (95% CI: 0.70-0.99) and 1.00 (95% CI: 0.74-1.00), respectively. The pooled sensitivity and specificity of FDG PET or PET/CT for staging or restaging (metastatic lesions) of bladder cancer were 0.82 (95% CI: 0.72-0.89) and 0.89 (95% CI: 0.81-0.95), respectively. Conclusion: The diagnostic accuracy of FDG PET or PET/CT is good in metastatic lesions of urinary bladder cancer. Due to the small number of patients and limited number of studies analyzed, the diagnostic capability of FDG PET or PET/CT in detection of primary bladder wall lesions could not be assessed.

KW - FDG PET

KW - Meta-analysis

KW - PET/CT

KW - Systemic review

KW - Urinary bladder cancer

UR - http://www.scopus.com/inward/record.url?scp=84864650406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864650406&partnerID=8YFLogxK

U2 - 10.1016/j.ejrad.2011.07.018

DO - 10.1016/j.ejrad.2011.07.018

M3 - Article

C2 - 21899971

AN - SCOPUS:84864650406

VL - 81

SP - 2411

EP - 2416

JO - European Journal of Radiology

JF - European Journal of Radiology

SN - 0720-048X

IS - 9

ER -